The promises and challenges of patient‐derived tumor organoids in drug development and precision oncology

The promises and challenges of patient‐derived tumor organoids in drug development and precision oncology

Abstract In the era of precision medicine, cancer researchers and oncologists are eagerly searching for more realistic, cost effective, and timely tumor models to aid drug development and precision oncology. Tumor models that can faithfully recapitulate the histological and molecular characteristics...

Full description

Bibliographic Details
Main Authors: Lauren M. Granat, Ooha Kambhampati, Stephanie Klosek, Brian Niedzwecki, Kian Parsa, Dong Zhang
Format: Article
Language:English
Published: Wiley 2019-09-01
Series:Animal Models and Experimental Medicine
Subjects:
drug testing
patient derived tumor organoids
precision oncology
tumor models
Online Access:https://doi.org/10.1002/ame2.12077

Similar Items

Similar Items